Skip to content
Every compound links to batch-tested stock at Nordapep, with a Certificate of Analysis per batch.
peptide.wiki

Semaglutide vs Cagrilintide

These two act on different hormone systems. Semaglutide mimics GLP-1 and activates the GLP-1 receptor. Cagrilintide mimics amylin and activates amylin and calcitonin receptors. Both are acylated for a half-life of about a week.

Long-acting GLP-1 receptor agonist

Choose Semaglutide if

  • ✓ You need the established GLP-1 reference compound
  • ✓ Evidence maturity matters most for your design
Buy Semaglutide

Long-acting amylin and calcitonin receptor agonist

Choose Cagrilintide if

  • ✓ Your question is about amylin or calcitonin receptor signalling
  • ✓ You are studying how a second pathway adds to GLP-1 activity
Buy Cagrilintide

Side-by-side specification

CompareSemaglutide
Long-acting GLP-1 receptor agonist
Cagrilintide
Long-acting amylin and calcitonin receptor agonist
ClassGLP-1 receptor agonistAmylin / calcitonin receptor agonist
Research areaMetabolicMetabolic
Receptor targetsGLP-1RAmylin and calcitonin receptors
Length31 amino acids (acylated GLP-1 analogue)37 amino acids (acylated amylin analogue)
Molecular mass≈ 4.11 kDa≈ 4.41 kDa
OriginSynthetic analogue of human GLP-1Synthetic analogue of human amylin
Evidence level
5/5
Approved drug, phase 3 trials
4/5
Late-stage human trials
Regulatory statusApproved prescription medicineInvestigational
Nordapep fromNot listedNot listed
Best price per mgNot listedNot listed
View Semaglutide at Nordapep →View Cagrilintide at Nordapep →

What separates them

Semaglutide is an approved medicine and cagrilintide is investigational on its own. Their combination, CagriSema, was submitted to the FDA in December 2025 and was still under review at the time of writing.

Read the full guides for Semaglutide and Cagrilintide, or add a third compound in the comparison tool.

Studying both?
Nordapep lists each with its own batch CoA. Its research stacks bundle common pairings.
See stacks at Nordapep

FAQ

What is CagriSema?

A fixed-dose combination of cagrilintide and semaglutide developed by Novo Nordisk. It is not approved at the time of writing.

Is cagrilintide a GLP-1 drug?

No. It targets the amylin and calcitonin receptors, not the GLP-1 receptor.

Are Semaglutide and Cagrilintide approved medicines?

Semaglutide: Approved prescription medicine. Cagrilintide: Investigational. Research-grade material of either is not a medicine and is supplied for in vitro research only.

Where can I buy Semaglutide and Cagrilintide?

Nordapep lists compounds with a Certificate of Analysis matched to the batch reference. Check each compound page for current availability.

More comparisons

For laboratory research only. Nothing on peptide.wiki is medical advice. The compounds described are not for human or veterinary use, and research-grade material is not a medicine.